IS7042A - (Pýridó/þíenó)-[f]-oxasepín-5-on afleiður - Google Patents

(Pýridó/þíenó)-[f]-oxasepín-5-on afleiður

Info

Publication number: IS7042A
Authority: IS; Iceland
Prior art keywords: oxazepin; thieno; pyrido; derivatives
Prior art date: 2001-06-14

Application number

IS7042A

Other languages

English (en)

Inventor

James Anthony Grove Simon

Adam-Worrall Julia

Zhang Mingqiang

Gilfillan Robert

Original Assignee

Akzo Nobel N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-14

Filing date

2003-11-17

Publication date

2003-11-17

2003-11-17 Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.

2003-11-17 Publication of IS7042A publication Critical patent/IS7042A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Reproductive Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

IS7042A 2001-06-14 2003-11-17 (Pýridó/þíenó)-[f]-oxasepín-5-on afleiður IS7042A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01202284		2001-06-14
PCT/EP2002/006364 WO2002102808A2 (en)	2001-06-14	2002-06-10	(PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR

Publications (1)

Publication Number	Publication Date
IS7042A true IS7042A (is)	2003-11-17

Family

ID=8180476

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7042A IS7042A (is)	2001-06-14	2003-11-17	(Pýridó/þíenó)-[f]-oxasepín-5-on afleiður

Country Status (25)

Country	Link
US (3)	US7345036B2 (is)
EP (1)	EP1446407A2 (is)
JP (1)	JP4435562B2 (is)
KR (1)	KR100864267B1 (is)
CN (2)	CN1255413C (is)
AR (1)	AR034482A1 (is)
AU (1)	AU2002320841B2 (is)
BR (1)	BR0210307A (is)
CA (1)	CA2449215C (is)
CO (1)	CO5550448A2 (is)
CZ (1)	CZ296217B6 (is)
EC (1)	ECSP034890A (is)
HR (1)	HRP20031013A2 (is)
HU (1)	HUP0400196A3 (is)
IL (2)	IL158928A0 (is)
IS (1)	IS7042A (is)
MX (1)	MXPA03011562A (is)
NO (1)	NO328710B1 (is)
NZ (1)	NZ529671A (is)
PE (1)	PE20030271A1 (is)
PL (1)	PL367185A1 (is)
RU (1)	RU2286347C2 (is)
SK (1)	SK287583B6 (is)
WO (1)	WO2002102808A2 (is)
ZA (1)	ZA200309096B (is)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200817385A (en) *	2006-07-04	2008-04-16	Organon Nv	Heterocyclic derivatives
GB0624879D0 (en) *	2006-12-14	2007-01-24	Shs Int Ltd	Treatment of pervasive development disorders
FR2964969B1 (fr) *	2010-09-16	2012-08-24	Servier Lab	Nouveaux derives dihydrobenzoxathiazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1238719A (is) *	1968-11-01	1971-07-07
PT651746E (pt)	1992-07-24	2002-09-30	Univ California	Drogas que intensificam as respostas sinapticas mediadas por receptores de ampa
JP3887785B2 (ja) *	1994-11-02	2007-02-28	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	５−ｈｔ２レセプター親和性を有する置換四環状オキサゼピン及びチアゼピン誘導体
DK0801651T3 (da)	1995-01-06	2001-10-22	Hoffmann La Roche	Hydroxymethyl-imidazodiazepiner og deres estere
US5650409A (en)	1995-06-02	1997-07-22	Cortex Pharmaceuticals, Inc.	Benzoyl piperidines/pyrrolidines for enhancing synaptic response
US5736543A (en)	1996-04-03	1998-04-07	The Regents Of The University Of California	Benzoxazines for enhancing synaptic response
ATE303997T1 (de) *	1997-06-09	2005-09-15	Pfizer Prod Inc	Chinazolin-4-on ampa antagonisten
US5985871A (en)	1997-12-24	1999-11-16	Cortex Pharmaceuticals, Inc.	Benzoxazine compounds for enhancing synaptic response
ZA991301B (en)	1998-02-18	1999-09-13	Neurosearch As	Glutamate receptor modulators.
US6124278A (en)	1998-04-03	2000-09-26	The Regents Of The University Of California	Acylbenzoxazines for enhancing synaptic response
CA2372791A1 (en)	1999-05-12	2000-11-16	Nouri Neamati	Thiazepine and oxazepine inhibitors of hiv-1 integrase
TWI232863B (en)	2001-06-11	2005-05-21	Akzo Nobel Nv	Benzoxazepine derivatives

2002
- 2002-06-10 PL PL02367185A patent/PL367185A1/xx unknown
- 2002-06-10 EP EP02754652A patent/EP1446407A2/en not_active Withdrawn
- 2002-06-10 NZ NZ529671A patent/NZ529671A/en unknown
- 2002-06-10 JP JP2003506280A patent/JP4435562B2/ja not_active Expired - Fee Related
- 2002-06-10 RU RU2004100702/04A patent/RU2286347C2/ru not_active IP Right Cessation
- 2002-06-10 SK SK1526-2003A patent/SK287583B6/sk not_active IP Right Cessation
- 2002-06-10 KR KR1020037016248A patent/KR100864267B1/ko not_active Expired - Fee Related
- 2002-06-10 CN CNB028118154A patent/CN1255413C/zh not_active Expired - Fee Related
- 2002-06-10 MX MXPA03011562A patent/MXPA03011562A/es active IP Right Grant
- 2002-06-10 CA CA2449215A patent/CA2449215C/en not_active Expired - Fee Related
- 2002-06-10 CZ CZ20033392A patent/CZ296217B6/cs not_active IP Right Cessation
- 2002-06-10 HU HU0400196A patent/HUP0400196A3/hu unknown
- 2002-06-10 US US10/480,569 patent/US7345036B2/en not_active Expired - Fee Related
- 2002-06-10 HR HR20031013A patent/HRP20031013A2/hr not_active Application Discontinuation
- 2002-06-10 CN CN2006100598858A patent/CN101029051B/zh not_active Expired - Fee Related
- 2002-06-10 AU AU2002320841A patent/AU2002320841B2/en not_active Ceased
- 2002-06-10 BR BR0210307-9A patent/BR0210307A/pt not_active Application Discontinuation
- 2002-06-10 IL IL15892802A patent/IL158928A0/xx active IP Right Grant
- 2002-06-10 WO PCT/EP2002/006364 patent/WO2002102808A2/en not_active Ceased
- 2002-06-13 AR ARP020102223A patent/AR034482A1/es unknown
- 2002-06-13 PE PE2002000511A patent/PE20030271A1/es not_active Application Discontinuation
2003
- 2003-11-17 IS IS7042A patent/IS7042A/is unknown
- 2003-11-18 IL IL158928A patent/IL158928A/en not_active IP Right Cessation
- 2003-11-21 ZA ZA200309096A patent/ZA200309096B/en unknown
- 2003-12-11 NO NO20035523A patent/NO328710B1/no not_active IP Right Cessation
- 2003-12-11 EC EC2003004890A patent/ECSP034890A/es unknown
- 2003-12-16 CO CO03109961A patent/CO5550448A2/es not_active Application Discontinuation
2008
- 2008-02-01 US US12/024,597 patent/US7566778B2/en not_active Expired - Fee Related
2009
- 2009-02-20 US US12/389,968 patent/US8034804B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL158928A0 (en)	2004-05-12
NZ529671A (en)	2005-10-28
ECSP034890A (es)	2004-01-28
HRP20031013A2 (hr)	2005-10-31
CA2449215A1 (en)	2002-12-27
RU2004100702A (ru)	2005-06-10
HUP0400196A2 (hu)	2004-07-28
ZA200309096B (en)	2005-02-21
IL158928A (en)	2008-11-26
HUP0400196A3 (en)	2007-05-02
AR034482A1 (es)	2004-02-25
CN101029051A (zh)	2007-09-05
KR20040007703A (ko)	2004-01-24
SK15262003A3 (sk)	2004-05-04
CA2449215C (en)	2011-03-22
MXPA03011562A (es)	2004-03-18
BR0210307A (pt)	2004-07-13
CN101029051B (zh)	2010-06-09
PE20030271A1 (es)	2003-03-19
US8034804B2 (en)	2011-10-11
KR100864267B1 (ko)	2008-10-20
US20090163473A1 (en)	2009-06-25
NO20035523D0 (no)	2003-12-11
US20080262221A1 (en)	2008-10-23
PL367185A1 (en)	2005-02-21
CZ20033392A3 (en)	2004-05-12
CN1516701A (zh)	2004-07-28
SK287583B6 (sk)	2011-03-04
US20040220175A1 (en)	2004-11-04
US7566778B2 (en)	2009-07-28
NO328710B1 (no)	2010-05-03
CN1255413C (zh)	2006-05-10
US7345036B2 (en)	2008-03-18
JP2005500301A (ja)	2005-01-06
WO2002102808A2 (en)	2002-12-27
CO5550448A2 (es)	2005-08-31
AU2002320841B2 (en)	2008-02-28
CZ296217B6 (cs)	2006-02-15
RU2286347C2 (ru)	2006-10-27
JP4435562B2 (ja)	2010-03-17
EP1446407A2 (en)	2004-08-18
WO2002102808A3 (en)	2003-03-20

Publication	Publication Date	Title
MA27043A1 (fr)	2004-12-20	Azaindoles
PT1406628E (pt)	2006-06-30	Derivados de tera-hidroquinolina
NO20042755L (no)	2004-06-29	Amidsubstituerte imidazopyridiner
PT1257276E (pt)	2006-05-31	Derivados de azaindole antivirais
NO20023828L (no)	2002-09-30	Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer
ATE312827T1 (de)	2005-12-15	3-substituierte-4-pyrimidonderivate
CY2014018I2 (el)	2015-12-09	Kαρβαμιδο - υποκατεστημενες πυραζολοπυριδινες
NO20032453L (no)	2003-07-16	Substituerte imidazopyridiner
NO20042356L (no)	2004-08-12	Tioetersubstituerte imidazokinoliner
ZA200309522B (en)	2005-02-23	Substituted cyclohexane-1-4diamine derivatives
DE60214428D1 (de)	2006-10-12	1, 4-dihydro-1, 4-diphenylpyridin-derivate
DK1412328T3 (da)	2007-02-12	Dolastatin-10-derivater
DK1608654T3 (da)	2010-04-26	8-substituerede-6, 7, 8, 9-tetrahydropyrimido (1,2- a) pyrimidin-4-on-derivater
NO20054331D0 (no)	2005-09-20	Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
EE200300447A (et)	2003-12-15	Asendatud bensofuraan-2-karboksamiidide derivaadid
HUP0303186A3 (en)	2007-06-28	4-aminobenzopyran derivatives
HUP0401949A3 (en)	2009-07-28	4-imidazolin-2-one derivatives
HUP0500026A3 (en)	2008-02-28	N-heteroarylnicotinamide derivatives
DE60223031D1 (de)	2007-11-29	Arylpiperazin gebundene tetrahydroindolonderivate
ATE382601T1 (de)	2008-01-15	Substituierte 4-aminocyclohexanolderivate
IS7042A (is)	2003-11-17	(Pýridó/þíenó)-[f]-oxasepín-5-on afleiður
EP1364954A4 (en)	2009-10-28	Dicarba closo DODECARBORANDERIVATE
DE60202381D1 (de)	2005-01-27	Paroxetin-n-formyl-derivate
ATE382628T1 (de)	2008-01-15	Tetrahydrobenzfluorenderivate
GB0129215D0 (en)	2002-01-23	Trioxane derivatives